Back to User profile » Dr Anja Schweizer
Papers published by Dr Anja Schweizer:
Blood pressure and fasting lipid changes after 24 weeks’ treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naïve patients with type 2 diabetes mellitus
Evans M, Schweizer A, Foley JE
Vascular Health and Risk Management 2016, 12:337-340
Published Date: 18 August 2016
Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes
Blüher M, Schweizer A, Bader G, Foley JE
Vascular Health and Risk Management 2014, 10:661-664
Published Date: 20 November 2014
A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study
Hassanein M, Abdallah K, Schweizer A
Vascular Health and Risk Management 2014, 10:319-326
Published Date: 28 May 2014
Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
Schweizer A, Halimi S, Dejager S
Vascular Health and Risk Management 2014, 10:15-24
Published Date: 24 December 2013
Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Schweizer A, Foley JE, Kothny W, Ahrén B
Vascular Health and Risk Management 2013, 9:57-64
Published Date: 15 February 2013
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W
Vascular Health and Risk Management 2013, 9:21-28
Published Date: 23 January 2013
Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus
Dejager S, Schweizer A, Foley JE
Vascular Health and Risk Management 2012, 8:339-348
Published Date: 18 May 2012
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Anja Schweizer, Sylvie Dejager, James E Foley, et al
Vascular Health and Risk Management 2011, 7:49-57
Published Date: 4 February 2011
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet
Serge Halimi, Anja Schweizer, Biljana Minic, James Foley, Sylvie Dejager
Vascular Health and Risk Management 2008, 4:481-492
Published Date: 6 June 2008